ロード中...
Sicca Syndrome Induced by Immune Checkpoint Inhibitor Therapy: Optimal Management Still Pending
Commenting on a recently published article on sicca syndrome linked to immune checkpoint inhibitor therapy, this letter to the editor shares another viewpoint on the management of this immune‐related adverse event.
保存先:
| 出版年: | Oncologist |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7011671/ https://ncbi.nlm.nih.gov/pubmed/32043780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0467 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|